Some of the drug regimens bring long-term risks

A breach in the defenses perhaps:

An upsurge in teenagers requesting hormones or surgeries to better align their bodies with their gender identities has ignited a debate among doctors over when to provide these treatments.

An international group of experts focused on transgender health last month released a draft of new guidelines, the gold standard of the field that informs what insurers will reimburse for care.

How about informing the well-being of the patient first?

A new chapter dedicated to adolescents says that they must undergo mental health assessments and must have questioned their gender identity for “several years” before receiving drugs or surgeries.

How about questioning the very idea of “gender identity”? How about not treating it as a real and detectable thing, as opposed to an idea in search of people to believe it?

Some of the drug regimens bring long-term risks, such as irreversible fertility loss. And in some cases, thought to be quite rare, transgender people later “detransition” to the gender they were assigned at birth. Given these risks, as well as the increasing number of adolescents seeking these treatments, some clinicians say that teens need more psychological assessment than adults do.

Ya think? It’s almost as if teenagers are easily influenced by their fellow teenagers, with whom they spend most of their time.

9 Responses to “Some of the drug regimens bring long-term risks”

Leave a Comment

Subscribe without commenting